Project Grant HT94252411006
Award Date
9/15/24
Completion Date
9/14/25
Dollars Obligated
$910K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This Project Grant award for $737,998.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program, will fund research by The University of Texas Southwestern Medical Center to target MNK signaling to prevent and reverse chronic pain caused by complex traumatic injury. The research aims to develop innovative therapeutic approaches to address this significant medical challenge affecting military personnel. As a prominent academic...
This $1,394,919 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of nonopioid analgesics to treat chronic pain. The University of Texas Health Science Center at San Antonio (UTHSCSA), a state-controlled research institution, is the prime grantee and will conduct this 3-year research project from August 2024 to July 2027. As a leading academic medical center, UTHSCSA will leverage its expertise in...
This $366,000 federal Project Grant award, titled "VALIDATION OF A NONOPIOID ANALGESIC PATHWAY IN HUMAN SENSORY GANGLIA AND SPINAL CORD," was issued on September 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award was granted to the University of Florida to conduct advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research will explore innovative...
This Project Grant award, valued at $399,729.00, was provided by the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a research project focused on the clinical effectiveness of nonopioid pain management approaches to improve outcomes among active-duty service members. The award was granted to the University of Illinois, which will conduct this research over a 2-year period from November 1,...
The University of Texas Southwestern Medical Center received a $1.46 million Project Grant award from the Department of the Army Medical Command to develop a small chemical drug targeting EphB1 for the treatment of chronic pain. The grant was awarded on September 30, 2021 with a completion date of September 29, 2024. The funding supports the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical...
This federal Project Grant award, totaling $1,012,894.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate pain reprocessing therapy for veterans with chronic back pain. The 4-year award, with a start date of September 30, 2024, will compare the efficacy of this therapy and examine facilitators and barriers to implementation. The University of Colorado-Denver is the prime awardee, with sub-awards going to Texas...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,640,000.00 to The University of Texas Southwestern Medical Center (UT Southwestern) to conduct research on the brain-to-bone and bone-to-brain axis after traumatic brain injury. The 4-year award, starting on September 1, 2025, will support advanced biomedical investigations to transform healthcare for military service members, veterans, and the...
This federal Project Grant award in the amount of $617,537 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 1, 2024 to August 31, 2027, supports research conducted by The University of Texas Southwestern Medical Center (UT Southwestern) to examine heterogeneity in response to disease-modifying therapy for multiple sclerosis. As a prominent academic medical center, UT...
This federal Project Grant award, valued at $363,160.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant funds the University of Texas Southwestern Medical Center, also known as Southwestern Medical School, to conduct research on the development of bioresorbable heart valves. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the broader public by...
The Defense Health Agency awarded a $492,927 Project Grant to The University of Texas Southwestern Medical Center in Dallas, Texas to conduct research on leveraging biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. This 3-year grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health...